What Researchers Did
Researchers conducted the first nationwide online questionnaire survey to gather baseline information on the clinical application of hyperbaric oxygen therapy in China.
What They Found
The survey included 1,924 institutions, 2,699 HBO2 chambers, and 11,266 practitioners across China, revealing that 86.9% of institutions were public hospitals and 70.0% of chambers were air pressurized. Most HBO2 departments (70.8%) were independent, 88.1% offered 24-hour emergency treatment, and 44.5% of institutions conducted 1,001 to 5,000 annual therapy sessions. The most frequently treated conditions were cerebrovascular diseases, carbon monoxide poisoning, and central nervous system injury.
What This Means for Canadian Patients
This study provides a snapshot of hyperbaric oxygen therapy infrastructure and practice in China, which may offer insights into the organization and delivery of similar services globally. While not directly applicable to the Canadian healthcare system, understanding international practices can inform discussions about resource allocation and service development for HBO2 in Canada.
Canadian Relevance
This study has no direct Canadian relevance as it focuses exclusively on the clinical application of hyperbaric oxygen therapy within China.
Study Limitations
The study identified shortcomings such as a shortage of doctors and technicians, and imbalances in emergency capacity, treatment facilities, and scientific research.